US Stock MarketDetailed Quotes

Aethlon Medical (AEMD)

Watchlist
  • 3.050
  • +0.290+10.51%
Close Jan 22 16:00 ET
  • 3.000
  • -0.050-1.64%
Pre 08:00 ET
2.97MMarket Cap-0.21P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aethlon Medical (AEMD) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Sep 30, 2025
(Q1)Jun 30, 2025
(FY)Mar 31, 2025
(Q4)Mar 31, 2025
(Q3)Dec 31, 2024
(Q2)Sep 30, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
25.10%-1.66M
1.87%-1.71M
24.52%-7.65M
34.80%-1.67M
15.44%-2.01M
18.11%-2.21M
29.60%-1.75M
3.57%-10.13M
12.94%-2.57M
-21.87%-2.38M
Net income from continuing operations
47.02%-1.49M
31.48%-1.76M
-9.66%-13.39M
-157.89%-6.25M
49.37%-1.75M
7.50%-2.81M
21.65%-2.57M
-1.48%-12.21M
1.68%-2.43M
-21.72%-3.47M
Operating gains losses
----
----
----
----
----
----
----
-85.13%21.14K
--17.86K
----
Depreciation and amortization
-6.95%79.87K
-3.98%82.64K
-5.43%339.56K
-2.29%83.86K
-8.38%83.81K
-6.13%85.83K
-4.72%86.06K
49.05%359.06K
7.91%85.83K
17.08%91.47K
Other non cash items
-47.90%73.08K
6,038.37%72.27K
3,422,326.57%4.89M
385,641.56%4.68M
12,587.63%70.68K
20,348.54%140.28K
-198.30%-1.22K
-99.41%143
-218.77%-1.22K
-104.12%-566
Change In working capital
-257.03%-397.01K
-130.08%-180.43K
-80.43%93.69K
32.29%-258.39K
-218.83%-500.46K
1,431.75%252.82K
30.91%599.73K
632.58%478.66K
53.50%-381.63K
-22.31%421.15K
-Change in receivables
----
----
----
----
----
----
----
--0
----
----
-Change in prepaid assets
-140.84%-82.57K
82.52%164.03K
1,213.40%113.92K
-4.23%-304.8K
210.55%126.65K
112.84%202.2K
-38.62%89.87K
-102.57%-10.23K
-355.34%-292.42K
-62.86%40.78K
-Change in payables and accrued expense
-721.16%-314.43K
-167.56%-344.46K
-104.14%-20.23K
152.02%46.4K
-264.87%-627.11K
144.41%50.62K
63.57%509.86K
520.56%488.89K
75.29%-89.2K
19.82%380.37K
Cash from discontinued investing activities
Operating cash flow
25.10%-1.66M
1.87%-1.71M
24.52%-7.65M
34.80%-1.67M
15.44%-2.01M
18.11%-2.21M
29.60%-1.75M
3.57%-10.13M
12.94%-2.57M
-21.87%-2.38M
Investing cash flow
Cash flow from continuing investing activities
0
144.67%2.19K
75.11%-2.19K
0
0
73.40%-250.87K
56.53%-4.91K
94.19%-8.81K
Net PPE purchase and sale
----
----
--0
144.67%2.19K
75.11%-2.19K
--0
--0
73.40%-250.87K
56.53%-4.91K
94.19%-8.81K
Cash from discontinued investing activities
Investing cash flow
----
----
--0
144.67%2.19K
75.11%-2.19K
--0
--0
73.40%-250.87K
56.53%-4.91K
94.19%-8.81K
Financing cash flow
Cash flow from continuing financing activities
97,728.44%3.74M
-100.10%-5.36K
500.14%7.73M
5,441.34%2.36M
-103.99%-7.07K
61.07%-3.83K
399.12%5.38M
-85.56%1.29M
1,715.02%42.57K
9,501.75%177.13K
Net common stock issuance
--3.74M
--0
167.69%3.54M
-3,806.44%-1.84M
--0
--0
395.74%5.38M
-85.19%1.32M
--49.76K
--186.5K
Proceeds from stock option exercised by employees
----
----
--4.37M
----
----
----
----
--0
----
----
Net other financing activities
12.73%-3.34K
-5.49%-5.36K
-428.45%-183.78K
-2,233.80%-167.8K
24.54%-7.07K
61.07%-3.83K
39.35%-5.08K
-178.38%-34.78K
-172.76%-7.19K
-397.51%-9.37K
Cash from discontinued financing activities
Financing cash flow
97,728.44%3.74M
-100.10%-5.36K
500.14%7.73M
5,441.34%2.36M
-103.99%-7.07K
61.07%-3.83K
399.12%5.38M
-85.56%1.29M
1,715.02%42.57K
9,501.75%177.13K
Net cash flow
Beginning cash position
-57.82%3.86M
1.26%5.6M
-62.18%5.53M
-39.04%4.91M
-32.32%6.95M
-29.46%9.16M
-62.18%5.53M
-14.80%14.62M
-54.17%8.06M
-47.88%10.26M
Current changes in cash
193.87%2.08M
-147.37%-1.72M
100.90%81.85K
127.24%688.6K
8.57%-2.02M
18.46%-2.22M
322.12%3.63M
-258.91%-9.09M
14.62%-2.53M
-4.99%-2.21M
Effect of exchange rate changes
22.95%6.25K
-1,101.24%-15.5K
-681.96%-12.26K
-7.31%-2.42K
-343.26%-13.64K
581.99%5.09K
-593.55%-1.29K
135.37%2.11K
62.11%-2.26K
--5.61K
End cash Position
-14.32%5.95M
-57.82%3.86M
1.26%5.6M
1.26%5.6M
-39.04%4.91M
-32.32%6.95M
-29.46%9.16M
-62.18%5.53M
-62.18%5.53M
-54.17%8.06M
Free cash flow
25.10%-1.66M
1.87%-1.71M
26.35%-7.65M
35.01%-1.67M
15.66%-2.01M
18.31%-2.21M
35.58%-1.75M
9.33%-10.38M
13.11%-2.57M
-13.51%-2.39M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Sep 30, 2025(Q1)Jun 30, 2025(FY)Mar 31, 2025(Q4)Mar 31, 2025(Q3)Dec 31, 2024(Q2)Sep 30, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 25.10%-1.66M1.87%-1.71M24.52%-7.65M34.80%-1.67M15.44%-2.01M18.11%-2.21M29.60%-1.75M3.57%-10.13M12.94%-2.57M-21.87%-2.38M
Net income from continuing operations 47.02%-1.49M31.48%-1.76M-9.66%-13.39M-157.89%-6.25M49.37%-1.75M7.50%-2.81M21.65%-2.57M-1.48%-12.21M1.68%-2.43M-21.72%-3.47M
Operating gains losses -----------------------------85.13%21.14K--17.86K----
Depreciation and amortization -6.95%79.87K-3.98%82.64K-5.43%339.56K-2.29%83.86K-8.38%83.81K-6.13%85.83K-4.72%86.06K49.05%359.06K7.91%85.83K17.08%91.47K
Other non cash items -47.90%73.08K6,038.37%72.27K3,422,326.57%4.89M385,641.56%4.68M12,587.63%70.68K20,348.54%140.28K-198.30%-1.22K-99.41%143-218.77%-1.22K-104.12%-566
Change In working capital -257.03%-397.01K-130.08%-180.43K-80.43%93.69K32.29%-258.39K-218.83%-500.46K1,431.75%252.82K30.91%599.73K632.58%478.66K53.50%-381.63K-22.31%421.15K
-Change in receivables ------------------------------0--------
-Change in prepaid assets -140.84%-82.57K82.52%164.03K1,213.40%113.92K-4.23%-304.8K210.55%126.65K112.84%202.2K-38.62%89.87K-102.57%-10.23K-355.34%-292.42K-62.86%40.78K
-Change in payables and accrued expense -721.16%-314.43K-167.56%-344.46K-104.14%-20.23K152.02%46.4K-264.87%-627.11K144.41%50.62K63.57%509.86K520.56%488.89K75.29%-89.2K19.82%380.37K
Cash from discontinued investing activities
Operating cash flow 25.10%-1.66M1.87%-1.71M24.52%-7.65M34.80%-1.67M15.44%-2.01M18.11%-2.21M29.60%-1.75M3.57%-10.13M12.94%-2.57M-21.87%-2.38M
Investing cash flow
Cash flow from continuing investing activities 0144.67%2.19K75.11%-2.19K0073.40%-250.87K56.53%-4.91K94.19%-8.81K
Net PPE purchase and sale ----------0144.67%2.19K75.11%-2.19K--0--073.40%-250.87K56.53%-4.91K94.19%-8.81K
Cash from discontinued investing activities
Investing cash flow ----------0144.67%2.19K75.11%-2.19K--0--073.40%-250.87K56.53%-4.91K94.19%-8.81K
Financing cash flow
Cash flow from continuing financing activities 97,728.44%3.74M-100.10%-5.36K500.14%7.73M5,441.34%2.36M-103.99%-7.07K61.07%-3.83K399.12%5.38M-85.56%1.29M1,715.02%42.57K9,501.75%177.13K
Net common stock issuance --3.74M--0167.69%3.54M-3,806.44%-1.84M--0--0395.74%5.38M-85.19%1.32M--49.76K--186.5K
Proceeds from stock option exercised by employees ----------4.37M------------------0--------
Net other financing activities 12.73%-3.34K-5.49%-5.36K-428.45%-183.78K-2,233.80%-167.8K24.54%-7.07K61.07%-3.83K39.35%-5.08K-178.38%-34.78K-172.76%-7.19K-397.51%-9.37K
Cash from discontinued financing activities
Financing cash flow 97,728.44%3.74M-100.10%-5.36K500.14%7.73M5,441.34%2.36M-103.99%-7.07K61.07%-3.83K399.12%5.38M-85.56%1.29M1,715.02%42.57K9,501.75%177.13K
Net cash flow
Beginning cash position -57.82%3.86M1.26%5.6M-62.18%5.53M-39.04%4.91M-32.32%6.95M-29.46%9.16M-62.18%5.53M-14.80%14.62M-54.17%8.06M-47.88%10.26M
Current changes in cash 193.87%2.08M-147.37%-1.72M100.90%81.85K127.24%688.6K8.57%-2.02M18.46%-2.22M322.12%3.63M-258.91%-9.09M14.62%-2.53M-4.99%-2.21M
Effect of exchange rate changes 22.95%6.25K-1,101.24%-15.5K-681.96%-12.26K-7.31%-2.42K-343.26%-13.64K581.99%5.09K-593.55%-1.29K135.37%2.11K62.11%-2.26K--5.61K
End cash Position -14.32%5.95M-57.82%3.86M1.26%5.6M1.26%5.6M-39.04%4.91M-32.32%6.95M-29.46%9.16M-62.18%5.53M-62.18%5.53M-54.17%8.06M
Free cash flow 25.10%-1.66M1.87%-1.71M26.35%-7.65M35.01%-1.67M15.66%-2.01M18.31%-2.21M35.58%-1.75M9.33%-10.38M13.11%-2.57M-13.51%-2.39M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -